Reintroduction of immunosuppressive medications in pediatric rheumatology patients with histoplasmosis: a case series

Abstract Background Children with rheumatic diseases (cRD) receiving immunosuppressive medications (IM) are at a higher risk for acquiring potentially lethal pathogens, including Histoplasma capsulatum (histoplasmosis), a fungal infection that can lead to prolonged hospitalization, organ damage, and...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rachel A. Brown, Fatima Barbar-Smiley, Cagri Yildirim-Toruner, Monica I. Ardura, Stacy P. Ardoin, Shoghik Akoghlanian
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-06-01
coleção:	Pediatric Rheumatology Online Journal
Assuntos:	histoplasmosis juvenile idiopathic arthritis immunosuppression tumor necrosis factor alpha inhibitor corticosteroid abatacept
Acesso em linha:	https://doi.org/10.1186/s12969-021-00581-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!